Related Experiment Video
Updated: May 12, 2026

Single-port Non-liposuction Endoscopic Axillary Lymph Node Dissection in Breast Cancer Surgery
Published on: April 3, 2026
Effect of gentamicin lavage of the axillary surgical bed after lymph node dissection on drainage discharge volume
Jaime Ruiz-Tovar1, Pilar Cansado, Montserrat Perez-Soler
1Department of Surgery, Breast Unit, General University Hospital Elche, Alicante, Spain.
Unlabelled:
The purpose of this study was to evaluate the effect of axillary lavage with a gentamicin solution before wound closure on drainage volume.
Patients And Methods:
A prospective, randomized study was performed. Inclusion criteria were a diagnosis of breast neoplasms and plans to undergo an elective axillary lymph node dissection due to axillary metastasis. The patients were randomized into 2 groups: patients undergoing 2 lavages with 500 ml normal saline (Group 1) and patients first undergoing lavage with 500 ml normal saline followed by a second lavage with a 500 ml of a gentamicin (240 mg) solution (Group 2). Microbiological samples were obtained before any lavage, after each lavage and at the time of drain removal.
Results:
40 patients were included. Mean number of days maintaining the drain in place was 7.7 ± 3.2 days in Group 1 and 4.3 ± 1.4 days in Group 2 (p = 0.001). Total drainage volume before removal was 465 ± 250.9 ml in Group 1 and 169 ± 102.2 ml in Group 2 (p = 0.003). After a second lavage with normal saline in Group 1 and after a lavage with gentamicin solution in Group 2, microbiological culture was positive in 10 patients (50%) in Group 1 and 1 case (5%) in Group 2 (p = 0.016). Positive cultures were associated with higher drainage volumes.
Conclusion:
The postoperative drainage volume of the axillary drain is significantly lower in the patients undergoing a lavage of the surgical bed with a gentamicin solution than in the control group undergoing a lavage with normal saline. A significant reduction in the contamination is only obtained after a lavage with gentamicin solution.
Clinical Trial Registration Number:
NCT01700504.
Related Concept Videos
Aneurysm IV: Nursing Management
Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations